Clinical Trials · NCT04555824
A Phase 1a Study of Thymosin Beta 4 in Healthy Volunteers
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Beijing Northland Biotech. Co., Ltd.
- Enrollment
- 54
- Start date
- Jul 2017
- Locations
- 1 site, China
- Primary endpoint
- Maximum Tolerated Dose (MTD) .